Mitochondrial Chaperones and Proteases in Cardiomyocytes and Heart Failure

被引:9
作者
Chen, Zee [1 ,2 ]
Huang, Lei [1 ]
Tso, Alexandria [3 ]
Wang, Shijia [2 ]
Fang, Xi [3 ]
Ouyang, Kunfu [1 ,2 ]
Han, Zhen [2 ]
机构
[1] Peking Univ, Dept Cardiovasc Surg, Shenzhen Hosp, Shenzhen, Peoples R China
[2] Peking Univ, Sch Chem Biol & Biotechnol, State Key Lab Chem Oncogen, Shenzhen Grad Sch, Shenzhen, Peoples R China
[3] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA
关键词
mitochondrial chaperone; mitochondrial protease; heart failure; cardiomyocyte; mitochondrial protein homeostasis; mitochondrial protein folding; mitochondrial protein degradation;
D O I
10.3389/fmolb.2021.630332
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heart failure is one of the leading causes of morbidity and mortality worldwide. In cardiomyocytes, mitochondria are not only essential organelles providing more than 90% of the ATP necessary for contraction, but they also play critical roles in regulating intracellular Ca2+ signaling, lipid metabolism, production of reactive oxygen species (ROS), and apoptosis. Because mitochondrial DNA only encodes 13 proteins, most mitochondrial proteins are nuclear DNA-encoded, synthesized, and transported from the cytoplasm, refolded in the matrix to function alone or as a part of a complex, and degraded if damaged or incorrectly folded. Mitochondria possess a set of endogenous chaperones and proteases to maintain mitochondrial protein homeostasis. Perturbation of mitochondrial protein homeostasis usually precedes disruption of the whole mitochondrial quality control system and is recognized as one of the hallmarks of cardiomyocyte dysfunction and death. In this review, we focus on mitochondrial chaperones and proteases and summarize recent advances in understanding how these proteins are involved in the initiation and progression of heart failure.
引用
收藏
页数:9
相关论文
共 50 条
[41]   Desmin loss and mitochondrial damage precede left ventricular systolic failure in volume overload heart failure [J].
Guichard, Jason L. ;
Rogowski, Michael ;
Agnetti, Giulio ;
Fu, Lianwu ;
Powell, Pamela ;
Wei, Chih-Chang ;
Collawn, James ;
Dell'Italia, Louis J. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 313 (01) :H32-H45
[42]   Role of (pro)rennin receptor in cardiomyocytes of heart failure rat model [J].
Peng, Hua ;
Wu, Zu-bo ;
Kong, Shuang-shuang ;
Li, Ling .
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (05) :640-643
[43]   Alterations in the heart mitochondrial proteome in a desmin null heart failure model [J].
Fountoulakis, M ;
Soumaka, E ;
Rapti, K ;
Mavroidis, M ;
Tsangaris, G ;
Maris, A ;
Weisleder, N ;
Capetanaki, Y .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (03) :461-474
[44]   New aspects of impaired mitochondrial function in heart failure [J].
Mariana G. Rosca ;
Charles L. Hoppel .
Journal of Bioenergetics and Biomembranes, 2009, 41 :107-112
[45]   Interplay of Mitochondrial Biogenesis and Oxidative Stress in Heart Failure [J].
Cooper, Marcus P. .
CIRCULATION, 2013, 127 (19) :1932-1934
[46]   Mitochondrial membrane transporters and metabolic switch in heart failure [J].
Vikas Kumar ;
T. R. Santhosh Kumar ;
C. C. Kartha .
Heart Failure Reviews, 2019, 24 :255-267
[47]   New aspects of impaired mitochondrial function in heart failure [J].
Rosca, Mariana G. ;
Hoppel, Charles L. .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2009, 41 (02) :107-112
[48]   Mitochondrial membrane transporters and metabolic switch in heart failure [J].
Kumar, Vikas ;
Kumar, T. R. Santhosh ;
Kartha, C. C. .
HEART FAILURE REVIEWS, 2019, 24 (02) :255-267
[49]   Mitochondrial dysfunction in heart failure: potential for therapeutic interventions [J].
Stanley, WC ;
Hoppel, CL .
CARDIOVASCULAR RESEARCH, 2000, 45 (04) :805-806
[50]   Alterations in mitochondrial function in cardiac hypertrophy and heart failure [J].
Moritz Osterholt ;
T. Dung Nguyen ;
Michael Schwarzer ;
Torsten Doenst .
Heart Failure Reviews, 2013, 18 :645-656